Acute myeloid leukaemia
Not yet recruitingA Study to Assess Effectiveness of IPN60340 with Drug Combination in Adults with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
A Study to Assess Effectiveness of IPN60340 with Drug Combination in Adults with Newly Diagnosed Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
- Disease:Acute myeloid leukaemia
- Substances:AzacitidineICT01+2
Germany- Participants:18–64 years · 65+ years
- Substances:Azacitidine
- Sponsor:Ipsen Pharma









